What have pharmacies paid for Capecitabine since 2013?
What pharmacies pay, not what you pay. Capecitabine has 2 products in the CMS NADAC survey, 2 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Capecitabine 500 MG Tablet: $27.41 per unit at the 2014 survey and $0.454 at 2026 (−98%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Capecitabine2 products in NADAC
2products with a price history
Capecitabine has 2 products in the CMS NADAC survey, 2 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
Between each product's first and latest year-end survey, 1 product costs pharmacies less and none costs more, by more than 5 percent, per unit as CMS states it.
1 of the changes rest on fewer than 3 priced NDCs at one end and are marked thin: a median over one or two NDCs reflects which NDCs were priced as much as a price movement.
This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.
Capecitabine 500 MG Tablet
Generic
$27.41 per unit at the 2014 year-end survey (4 NDCs) and $0.454 at the 2026 survey (17 NDCs): −98%.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2014 (2014-12-31)
$27.41
4
2015 (2015-12-30)
$23.69
5
2016 (2016-12-28)
$17.04
9
2017 (2017-12-27)
$10.82
11
2018 (2018-12-26)
$4.30
14
2019 (2019-12-25)
$3.69
17
2020 (2020-12-30)
$0.586
19
2021 (2021-12-29)
$0.620
21
2022 (2022-12-28)
$0.559
20
2023 (2023-12-27)
$0.548
18
2024 (2024-12-25)
$0.467
15
2025 (2025-12-31)
$0.531
18
2026 (2026-11-11)
$0.454
17
Capecitabine 150 MG Tablet
Generic
$8.27 per unit at the 2014 year-end survey (2 NDCs) and $0.362 at the 2026 survey (11 NDCs): −96%, a thin comparison.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2014 (2014-12-31)
$8.27
2
2015 (2015-12-30)
$7.24
3
2024 (2024-12-25)
$0.257
13
2025 (2025-12-31)
$0.396
15
2026 (2026-11-11)
$0.362
11
CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.
Where does Capecitabine sit on the generic price cliff?
Capecitabine 500 MG Tablet: the first generic approval in its Orange Book group is dated 2013. Its year-end acquisition cost in 2026 is 2% of its first observed year-end price (2014). The median matched product, 13 years after its first generic approval, is at 19% (the middle half runs from 14% to 39%), so this product is below that middle half.
median of 200 matched productsmiddle halfeach productCapecitabine 500 MG Tablet
This is a pattern in matched products. It does not say the first generic caused the fall, and it does not say this product's price will follow the median. See it with other drugs.